Hos patienter, som fik foretaget ikke- primær PCI 6- 24 timer efter sidste fondaparinuxdosis, var den mediane UFH- dosis 8. 000 IE, og incidensen af svær blødning var 2% (2/ 98).
In those patients who underwent non-primary PCI 6-24 hours after the last dose of fondaparinux, the median dose of UFH was 8,000 IU and the incidence of major bleeding was 2% (2/ 98).